Home » Authors » Nuala Moran

Articles by Nuala Moran

Antisoma Buying Aptamera In £11.5M All-Share Merger

Jan. 12, 2005

Paradigm Buys Amedis, Brings In £5.5M From Existing Investors

Jan. 12, 2005

Antisoma Buying Aptamera In £11.5M All-Share Merger

Jan. 12, 2005

Paradigm Buys Amedis, Brings In £5.5M From Existing Investors

Jan. 12, 2005

Antisoma Buying Aptamera In £11.5M All-Share Merger

Jan. 11, 2005

Report from Europe: Stem Cell Foundation planned to help bridge UK funding gap

Jan. 11, 2005

Antisoma Buying Aptamera In £11.5M All-Share Merger

Jan. 11, 2005

Arrow Spins Out Immunoprime To Focus On Infectious Disease

Jan. 5, 2005

Stem Cell Foundation Planned To Help Bridge UK Funding Gap

Jan. 5, 2005

Stem Cell Foundation Planned To Help Bridge UK Funding Gap

Jan. 5, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...